DEFINITIVE PROXY STATEMENT

Company

Edesa Biotech, Inc.

Filed

April 4, 2025

Period of Report

May 28, 2025

Accession Number

0001171843-25-002028

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →